Discover the full directors' dealings record of 환인제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 환인제약 has published 20 reports. Market capitalisation: €153.7bn. The latest transaction was disclosed on 11 May 2026 (Other). Among the most active insiders: 이원범. All data is openly available.
20
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.